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Summary We have recently used two-dimensional DNA typing to detect genetic alterations in breast
tumours. This method, which is based on size separation in neutral gels and sequence separation in denaturing
gradient gels followed by hybridisation analysis with mini- and microsatellite core probes, allows the simul-
taneous analysis of hundreds of allelic fragments in a very short time. Here we demonstrate the potency of this
method for total genome scanning of the tumour genome by analysing a small series of breast cancers.
Comparison of tumour and normal DNA from ten breast cancer patients, using two-dimensional DNA typing
with four core probes, revealed a considerable number of genomic alterations. In contrast, with Southern blot
analysis only a few alterations were observed using the same probes. Most of the changes observed (74%) were
deletions (absence of spots in the tumour) while 20% corresponded to amplifications (spots of higher intensity
in the tumour) and 5% were new spots (gains). About 10% of the genomic changes detected appeared to
occur in the tumours of more than one patient.
Somatic DNA changes play a critical role in the induction
and progression of cancer. The results of molecular and
epidemiological studies indicate that the induction of cancer
in mammals requires the accumulation of several indepen-
dent mutations (Peto et al., 1975). Mutations affecting a wide
range of cellular functions, including growth control,
invasion, metastasis and the rate of mutation accumulation
itself, can affect the progression of cancer. Such key genetic
lesions in the tumour could be of clinical relevance for
diagnosis or as a prognostic indicator. Early detection of the
relevant changes, i.e. in the primary malignancy, could pro-
vide guidelines for better treatment, which is especially
relevant in heterogeneous cancers such as breast cancer, non-
small cell lung cancer and others. In such tumours combina-
tions of mutations are seen. Although recently much inform-
ation has been obtained on some of the most frequently
occurring genomic changes, there is as yet no complete
insight into the individual mutation spectra determining the
biological properties of the tumour. Indeed, such basic
insight would allow the development of combination
therapies targeted to various steps in cancer progression
(Russell, 1992).
Thus far the lack of genome-scanning methods has effec-
tively constrained the large-scale analysis of individual
tumours for specific DNA changes that could be correlated
with behavioural characteristics of the malignancy. We have
recently demonstrated the usefulness of a two-dimensional
(2-D) DNA electrophoretic approach for the rapid analysis
of cancers for genomic change (Hovig et al., 1993). In this
system, which is based on separation by size followed by
sequence-specific separation in denaturing gradient gels, large
numbers of polymorphic micro- and minisatellite loci can be
screened for deletions and amplifications through sequential
hybridisation to core probes (Uitterlinden et al., 1989). The
large number of detectable genetic polymorphisms makes
2-D DNA typing unique among genome-scanning techniques,
including other 2-D DNA separation techniques, such as the
restriction landmark genome scanning (RLGS) technique
(Hirotsune et al., 1992). RLGS detects only 0.15% of
polymorphic spots among all spots detected in human DNA
of unrelated individuals (Y. Hayashizaki, personal com-
munication). This effectively constrains application of RLGS
in human genetic studies, including analysis of the tumour
genome for instabilities. Two-dimensional DNA typing, in
particular, allows many individual chromosomes of the com-
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plete diploid set in each cell to be assessed for genetic lesions.
The availability of the resulting polymorphic markers for
genomic regions that can be associated with particular
tumour characteristics allows a more direct study of genetic
risk factors.
In the present study we have used Southern analysis and
2-D DNA typing to compare genomic DNAs from tumours
and blood samples from 18 breast cancer patients. With 2-D
DNA typing considerably more genomic sites could be
analysed with each probe than with Southern analysis; with
four probes the latter method produced about 90 bands,
while with 2-D DNA typing the same probes yielded about
900 spots. Certain spot changes appeared to occur in more
than one tumour. These variants are isolated from the gel
and tested further for their use as prognostic indicators and/
or susceptibility markers.
Materials and methods
Patient material
Material for this study was obtained- from 18 breast cancer
patients admitted to the Norwegian Radium Hospital (Table
I; see also Andersen et al., 1992). The observation time
ranged from 0 to 39 months. Local recurrences as well as
distant metastases were included in the term 'recurrence'.
Peripheral venous blood from each patient was collected in
EDTA and stored at -40°C until isolation of DNA. Tissue
from 17 primary invasive breast carcinomas and one local
recurrence (no. 78) was frozen in liquid nitrogen immediately
after surgery. Formalin-fixed material from each case was
processed for light microscopy and classified by a pathologist
according to the WHO recommendations. Contamination
with normal cells was scored by eye. All the samples con-
tained more than 50% tumour cells. Furthermore, each case
was TNM classified according to the UICC guidelines.
DNA isolation and restriction enzyme digestion
High molecular weight genomic DNA was isolated from the
white blood cells (WBC) and tumours according to standard
procedures (Kunkel et al., 1977) and digested with HaeIII
restriction enzyme according to the manufacturer's recom-
mendations (BRL, USA).
Preparation ofSouthern blots
For Southern blot preparation 5 lag of HaeIII-digested DNA
was fractionated in a 1% agarose gel in 1 x TAE
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Table I Overview of the breast tumours of the patients analysed in
this study
Patient no. Node status Recurrence (months)a Histology
16 0 -(32) Ductal
18 0 -(28) Ductal/lobular
31 0 -(39) Ductal
32 2 +(16) Ductal
33 0 -(39) Ductal
38 0 -(37) Ductal
43 0 -(36) Ductal
45 0 +(18) Ductal
51 1 -(38) Ductal
54 1 +(26) Lobular
57 1 -(34) Lobular
59 0 -(38) Ductal
61 1 +(0) Ductal
65 1 +(31) Ductal
67 2 +(0) Ductal
70 2 +(0) Lobular
71 2 +(8) Ductal
78b Ductal
aTime (in months) to recurrence is indicated. In the cases without
recurrence, time of observation is indicated. bThe tumour in this
patient was a locoregional recurrence.
(40 mM Tris-HAc pH 7.4, 33 mM sodium acetate, 1 mM
disodium EDTA) for 1,700 V h (2 V cm-'). After ethidium
bromide staining the DNA separation patterns were transfer-
red to a nylon membrane (Hybond N+, Amersham) by
vacuum blotting (VacuGene, Pharmacia) in 0.4M sodium
hydroxide, 0.6 M sodium chloride, for 1 h. DNA fragments
were cross-linked to the membrane by exposure to 302 nm
UV light (Transilluminator, UV Products, USA) for
1 min.
Preparation of2-D DNA typing blots
Two-dimensional separations of 10jig of restriction enzyme-
digested genomic DNA were performed in 1 mm-thick poly-
acrylamide (PAA) gels (acrylamide-bisacrylamide, 37.5:1)
using a gel apparatus that was essentially the same as
previously described (Fischer & Lerman, 1979). The first
dimension was run in a neutral 6% gel at 50°C for 3 h at
200 V in 0.5 x TAE. The separation patterns were visualised
by staining the gel with ethidium bromide (0.1 gml-') for
30 min, followed by destaining for at least 10 min. From a
given lane, the 0.4 to 4 kb region was used for 2-D separa-
tion. Lanes were cut out of the I-D gel and applied to a 6%
PAA gel containing a 10-75% linear concentration gradient
of denaturant (100% denaturant = 7.0 M urea, 40% for-
mamide) parallel to the direction of electrophoresis. Gels
were poured by mixing two solutions, containing the desired
boundary denaturant concentrations, in a gradient maker
(Pharmacia) with a peristaltic pump (BioRad). Electro-
phoresis was performed for 13.5 h at 60°C and 200 V
(12 Vcm-'). After 2-D electrophoresis, the DNA fragments
in the separation patterns were first fragmented by irradiat-
ing the gel with 302 nm UV light for 4 min. Transfer to a
nylon membrane (Hybond N+, Amersham) was achieved by
semidry electroblotting at 400 mA (6-28 V) between horizon-
tal ceramic (anode) and stainless-steel (cathode) plates with
the cathode as the top place. Electroblotting was performed
for 1.5 h between six Whatman 3MM paper sheets, which
were soaked in 0.5 x TBE (89 mMTris, 89 mM boric acid,
2mM disodium EDTA). For denaturation of membrane-
bound DNA fragments, filters were incubated in 0.4 M
sodium hydroxide, 0.6M sodium chloride for at least 1 h
followed by neutralisation by rinsing with 2.5 x SSC
(1 x SSC = 150 mm sodium chloride, 15 mM sodium citrate).
Subsequently, the filter was air dried and irradiated for 1 min
with 302 nm UV light to cross-link the DNA fragments to
the filter.
Probe preparation and labelling
The probes used in this study were microsatellite core probes
(CAC)Q, (TCC)n, (GACA)n, (GATA)n, and TELO
[= (TTAGGG)n], and minisatellite core probes 33.6, 33.15,
INS and HBV-1. These probes and the protocol followed to
prepare double-stranded DNA probes consisting of tandem
repeat motifs have been described in detail elsewhere (Uitter-
linden & Vijg, 1993). Briefly, two partially complementary
and overlapping oligonucleotides were individually phos-
phorylated by T4 kinase (Boehringer). Subsequently, the two
oligonucleotides were mixed and allowed to anneal at 42°C
for 1 h, followed by ligation according to standard proce-
dures. After phenol extraction and ethanol precipitation,
20ng of the ligation products were [X32P]dCTP labelled by
the random-primed oligolabelling method (Boehringer), after
boiling for 5 min and reannealing at 30°C in the presence of
1 unit of Klenow enzyme (BRL), 2IlM dNTP, 50 mM Tris-Cl
pH 7.2 and 10 mM magnesium chloride.
Hybridisation analysis
Hybridisation analysis of filters was performed in glass tubes
in a hybridisation oven (GFL) at 65°C. Filters were prehy-
bridised in 7% SDS, 0.5 M sodium phosphate pH 7.2, 1 mM
disodium EDTA for 5 min and hybridised in the same solu-
tion for 1 h. The filters were washed twice for 30 min at 65°C
in 2.5 x SSC, 0.1% SDS, and exposed to Kodak XAR film
in cassettes with intensifying screens for 2-48 h at -20°C.
The filters were rehybridised after stripping at 100°C in
0.1 x SSC, 0.1% SDS, for 5 min and subsequent washing at
65°C in 0.1 x SSC, 0.1% SDS.
Interpretation ofhybridisation patterns
Tumour and normal DNAs were always run on one gel to
facilitate interpretation. One- and two-dimensional DNA typ-
ing patterns were compared by eye independently by two
investigators, for differences between tumour and normal
tissues. Two-dimensional DNA typing patterns were com-
pared using a grid, and spots, detected by the core probes
used, that occur in all individuals analysed (constant spots;
see Figure 5). In 2-D DNA typing differences were only
scored if present in at least two independent experiments (see
Results). Differences include increases (>2-fold) in spot
intensity, referred to as gains/amplifications, decreases (>2-
fold) in spot intensity referred to as losses and shifts
(>5 mm) in spot position in either the x- or y-direction.
Band and spot patterns, including the differences observed,
were corrected for overlap among different core probes (i.e. a
band or spot being detected by more than one core probe).
The percentage overlap is expressed as the fraction of com-
mon bands/spots of the total detected by two core probes
and was found to be 7% (range 6-12%) on average in 2-D
DNA typing for the probes used here (Uitterlinden & Vijg,
1993).
Results
Southern blot analysis
As a general check we first performed Southern blot analyses
of all tumour/blood combinations, using nine micro- and
minisatellite core probes. Figure 1 shows examples after hy-
bridisation with core probes 33.15 and TELO. All probes
were found to generate multilocus patterns except (GACA)n,
which detected fewer than ten bands per individual, and
TELO, which detected a smear of large fragments (derived
from the heterogeneous chromosome ends) and very few
small fragments. After correction for overlap, in total an
average of 170 bands were scored per individual. Overlap of
bands detected was most prominent between (CAC)Q and
33.15 (30%), (CAC), and INS (24%), TCC and 33.6 (27%)
and GATA, TCC and INS (27%).
In most tumours DNA changes were observed (on average
five changes per individual for all probes), albeit with varying86 A.M. VERWEST et al.
Breast tumours
Patient 43 45 51 54 57 59 61 65
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N T N T N T N T
57 59 61 65
N T N T N T N T
TELO
Figure 1 Southern blot analysis of breast tumour DNA (T) and WBC DNA (N) from eight different patients using core probes
33.15 and TELO. Arrows indicate band losses, dots indicate amplifications. Size is in kilobase pairs (kb).
frequencies (Table II). In total 73% of the changes detected
were band losses in the tumour, while 27% were band gains
and/or amplifications. Some probes were more efficient than
others in detecting differences in relation to the total number
of bands detected. While (GATA)" and HBV-1 detected
relatively few differences (1.2% and 1.5% respectively),
(CAC)" and 33.6 were more efficient in this respect (5.4%
and 4.5% respectively). Notably, core probe 33.6 detected
almost exclusively losses of bands. For core probe TELO
downshifts of the midpoint of the smear (average size of
TTAGGG-containing chromosome ends; see Figure 1) were
detected in tumour DNA of 11 patients, while one patient
had an upshift. For core probe HBV-1 we observed in all but
two patients a distinct very large band (>20 kb) in tumour
DNA, while a slightly smaller smear was present in the WBC
DNA. Since WBC DNA was compared with breast tumour
tissue DNA, we cannot exclude that this is the result of
tissue-specific organisation of this sequence. No particular
changes were found to be shared by patients.
Two-dimensional DNA typing
The reproducibility of 2-D DNA typing in general has been
assessed previously by analysing one DNA sample multiple
times pairwise on one gel and on different gels. The results
(on marker fragments and spots obtained by hybridisation
analysis with probe 33.15) indicate an average inter-gel devia-
tion in spot position of about 1.5 and 2.5 mm in the x- and
y-direction respectively (Uitterlinden & Vijg, 1993).
A second type of error is the lack of recurrence of a spot
known to be present in a given DNA sample and the occur-
rence of spots due to artefacts. With respect to the former, it
was found (from the same set of repeated analyses) that
currently on average 1 out of 100 spots cannot be reproduced
on the same gel; on different gels 1 out of 50 spots do not
recur (Uitterlinden & Vijg, 1993). Spots as a result of, for
example, contamination with dirt particles or other artefacts
rarely occur and can easily be distinguished from genuine
spots. It should be noted that among different DNA samples
variation can occur in the total number of spots detected. In
general, fewer spots are detected when more stringent hyb-
ridisation and washing conditions are applied, when smaller
amounts (<5fig) of genomic DNA are loaded on the gel or
when DNA quality is low (extensively discussed in Uitter-
linden & Vijg, 1993). For 2-D DNA typing the quality of the
DNA isolated is more important than for the relatively sim-
ple standard Southern blot analysis. This is because single-
strand breaks have an effect on the second-dimension separa-
tion process (Uitterlinden & Vijg, 1993). This can be assessed
by alkaline agarose gel electrophoresis of undigested genomic
DNA (Sambrook et al., 1989). Upon such analysis, 10 out of
18 tumour/normal DNA samples used for the Southern blot
analyses appeared to be suitable for 2-D DNA typing.
The tumour/WBC combinations were analysed with four
different probes: 33.15, 33.6, (CAC)" and TELO. The first
three probes generated multilocus hybridisation patterns con-
taining approximately 300 spots, while TELO resulted in a
simple spot pattern consisting of about 50 spots. On average,
863 spots were scored for all probes together per individual
after correction for spot overlap. Because of the much higher
resolution of 2-D DNA typing, the overlap detectable is
much less than for Southern blot analysis (overlap between
any of the four probes varies from 6 to 12%). Figure 2 shows
two-dimensional spot patterns of tumour and normal WBC
DNA from patient 43 after hybridisation with core probes
33.15 and TELO.
A considerable fraction of the spots observed in the 2-D
DNA types generated with probes 33.15, 33.6 and (CAC)" is
polymorphic, that is spot variants can be observed between
different individuals. From the analysis of human reference
pedigrees of the Centre d'Etude Polymorphisme Humain
(CEPH; Paris, France) this fraction is estimated to be at least
80% (E. Mullaart et al., manuscript in preparation). For
TELO the polymorphic fraction is considerably lower.
On average we detected 18 differences per individual for
the four probes together (range 7-37). In all patients
differences were observed (on average 2.1%; range
1.1-5.2%) between tumour and normal (blood) tissue. The
differences observed are summarised in Table III. Some
details of the 2-D DNA typing patterns of the WBC and theTWO-DIMENSIONAL DNA TYPYING OF BREAST CANCERS 87
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Figure 2 Two-dimensional DNA typing patterns of breast tumour DNA (tumour) and WBC DNA (normal) from patient 43 after
hybridisation with core probes 33.15 and TELO. Squares indicate spot losses in tumour DNA and the corresponding spot position
in normal DNA. UF, urea/formamide denaturant.
corresponding tumour tissue are shown in Figure 3. To
assess the reproducibility of the spot differences found, each
comparison between tumour and normal DNA was per-
formed at least in duplicate. Table IV shows the results of
these replicate experiments. Spot differences found in hyb-
ridisation patterns of one gel could be reproduced in about
50% of the cases in the corresponding patterns from another
gel. Only these reproducible spot differences were used in
Table III, which is therefore an underestimate of the real
number of differences.
As in the Southern blot analysis, 74% of the differences
appeared to be spot losses in the tumour, while 26% spot
gains/amplifications were observed. Of the latter, 20% were
amplifications, 5% involved gains and 1% were other types
of differences such as shifts in spot position. Probes 33.15,
33.6 and TELO were more efficient in detecting spot
differences than (CAC)", although TELO detected fewer
spots than 33.15 and 33.6. Similar to what was found for the
Southern blot analysis, probe 33.6 almost exclusively detected
spot losses. From Table III it can be derived that the fre-
quency of changes (percentage of tumour-specific spot
variants) differed considerably from patient to patient. In this
respect the results corroborate the Southern blot analyses,
albeit a much larger number of detected loci substantiate the
2-D DNA typing results [i.e. a total number of 863 spots
scored as compared with 91 bands (for the four probes) in
the Southern blot analysis]. The variation among patients is
illustrated by Figure 4, in which the genetic changes detected
with core probes 33.6, 33.15, (CAC)n, and TELO by
Southern analysis were combined with those obtained by 2-D
DNA typing with the same core probes (for the 1-D results
20% overlap was used to correct for the total number of
bands detected). The figure indicates that the micro- and
minisatellite core probes used have the same tendency but
detect different spectra among patients with respect to the
frequency of changes detected in a given patient. By compar-
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Figure 3 Details taken from 2-D DNA typing patterns of normal versus tumour DNAs from three different patients after
hybridisation with probe 33.6. Squares indicate spot losses, arrows indicate shifts in position.
Table IV Reproducibility of spot differencesa
Patient
no. Gel no.
38 188
150
43 145
161
45 183
162
51 184
62
54 172
185
57 158
175
59 199
159
200
61 151
176
65 177
170
71 144
168
78 140
178
Total no.
of diff.b
11
14
14
13
11
15
9
6
11
14
18
14
10
12
6
6
1
6
3
19
12
S
11
No. of
reproducible dif.
S
11
11
6
6
S
6
6
8
8
6
6
6
1
1
2
2
9
9
3
3
Average
Percentage
45
36
79
85
55
40
56
83
55
43
44
57
60
50
100
17
100
33
67
47
75
60
27
59
aDetected by probe 33.15. bTotal number of differences detected
between WBC DNA and tumour DNA.
ing 2-D DNA typing patterns for each core probe for
different patients we could detect differences occurring in
more than one patient. Figure 5 shows the standardised 2-D
gel positions of all such differences.
54 57
Patient no.
Figure 4 Percentage of genetic changes of the total number of
fragments detected by both 2-D DNA typing and Southern blot
hybridisation analysis, in breast tumours of different patients
using each of four different core probes [33.6 (O), 33.15 (0),
(CAC)Q (*), and TELO (O)]. Sample 78 is a local recur-
rence.
In view of the small number of individual tumours
analysed no attempt was made to test for significant associa-
tions between spot changes and node status or recurrence.
Discussion
In the present paper we demonstrate the potenty of 2-D
DNA typing in genomic scanning of primary breast tumours.
In each breast cancer analysed at least four genomic changesTWO-DIMENSIONAL DNA TYPYING OF BREAST CANCERS 91
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Figure 5 Standardised positions in the 2-D DNA typing patterns of tumour-specific spot variants detected in at least two different
patients using four different core probes [33.15, 33.6, (CAC), and TELO]. For each core probe used the standardised grid and the
constant spots used to compare different gels are shown. Circles indicate gains/amplifications. Squares indicate spot losses.
Numbers adjacent to the circles/squares indicate the patient number.
could be observed, making this approach the most infor-
mative genome scanning technique currently available. The
total number of 863 spots detected should correspond to at
least half this number of loci, assuming 100% heterozygosity,
no overlap and no HaeIII-sensitive sites in the detected
alleles. In segregation studies using the CEPH panel of mul-
tigenerational pedigrees we have established that about 80%
of the spots for a given probe (probe 33.6) behave in a
Mendelian fashion and thus correspond to alleles of
polymorphic loci (te Meerman et al., 1993; Mullaart et al.,
manuscript in preparation).
The high-resolution genome coverage can easily be
extended by sequential rehybridisations with additional pro-
bes. The 2-D system is therefore much more powerful than
Southern analysis in assessing the amount of genetic change
in tumours. It should be noted that because of the different
size range other DNA fragments are detected in this 2-D
approach than in the standard Southerns; in the latter,
agarose-based system, only the large alleles can be scored. In
this sense the 1-D and 2-D approaches are complementary.
To improve the efficiency of 2-D DNA typing in scoring
polymorphic loci even further, the system can be coupled to
automated image analysis and database programs. Such pro-
grams, which are commercially available, are presently being92 A.M. VERWEST et al.
tested for their efficiency in rapidly interpreting 2-D DNA
typing patterns.
From this study it appears that the majority (74%) of
genetic changes detected involve deletiops of bands/spots,
whereas amplifications represent only 20% and gains 5%. In
this respect genome scanning by 2-D DNA typing using
micro- and minisatellite core probes provides a more accurate
representation of genomic alteration in tumour genomes than
alternative approaches such as RLGS, in which only
amplifications can be detected (Hirotsune et al., 1992). We
are currently extending the 2-D DNA typing analysis by
including more tumour samples from the same series of
patients (Andersen et al., 1992). Since these tumours have
also been genotyped for a number of loci, this allows the
results on allelic imbalance obtained by 2-D DNA typing to
be compared with those obtained using locus-specific
markers.
New spots (gains) are most likely due to somatic mutations
at the loci detected by the micro- and minisatellite core
probes used. These loci include the hypervariable VNTR loci,
mutations in which could arise through a number of
mechanisms (Thein et al., 1987; Armour et al., 1989). Such
mutations do not necessarily occur in the tumour during
development and progression, but could also reflect muta-
tions pre-existing in the normal cells from which the tumour
arose.
To circumvent the lack of immediate information on the
locus involved in a particular change, it is possible to obtain
spots of interest by direct isolation from the gel. A simple
and rapid procedure to accomplish this has recently been
developed (W.J.F. de Leeuw et al., submitted). Therefore,
large-scale 2-D DNA typing of tumours allows the rapid
development of large series of probes specific for particular
genomic changes in a given cancer. Alternatively, spots can
be identified on the basis of co-segregation with known
marker alleles, for example by using the CEPH panel.
Preliminary results indicate that this is feasible and a 2-D
DNA typing genetic map is presently under construction
(Mullaart et al., manuscript in preparation). The availability
of such a map will allow direct identification of variant spots
in tumour tissue. Probes in the chromosomal region
identified by the spots of interest can then be obtained from
genomic libraries.
Using 2-D DNA typing the degree of genetic instability in
a particular neoplasm can be assessed by scanning the total
genome at high resolution. The higher genetic lability of
tumours as compared with normal tissues is well documented
(Nowell, 1976; Volpe, 1988). It should be noted that any
distinction among tumour genomes with respect to genetic
variability might be due to differences in (clonal) hetero-
geneity of the tumour tissue. Multiclonal tumours in which
each clone will differ at multiple loci will result in a 2-D
DNA typing pattern with few consistent differences from
normal. Breast cancer early stages may be heterogeneous and
of polyclonal nature before convergence to monoclonality
takes place (Borg, 1992). It is not inconceivable that such an
evolutionary process is reflected in the patterns of genetic
changes we observed. However, any definite conclusions can
only be drawn when results on many more samples become
available.
The results obtained in this present study revealed a
number of specific changes (amplifications and deletions) in
breast cancers which had occurred in more than one patient.
These spots correspond to alleles these patients happen to
share in their normal DNA and which display allelic
imbalance in the tumour. Such spots are therefore likely to
be derived from loci more or less frequently involved in
tumorigenesis and/or tumour progression. In this respect it
should be noted that spot variants found to be on the same
isotherm in the denaturing gradient (second dimension) could
be alleles from the same locus (Uitterlinden & Vijg, 1991;
Hovig et al., 1993). These (polymorphic) spot variants
(Figure 5) are prime candidates for follow-up studies. Indeed,
some of these spots have been isolated directly from the gel
and are presently being tested as locus-specific probes on
larger numbers of primary breast tumours for their suitability
as prognostic indicators. The polymorphic nature of these
probes allows their use in studying genetic susceptibility of
breast cancer. Finally, the availability of ample genetic
markers will greatly facilitate the identification and isolation
of genes determining tumour behaviour and susceptibility.
We thank Dr T.A.W. Splinter (Department of Oncology, Academic
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